Elizabeth Boes, DO
Urology · Warren, MINPI 1760863773
Payments from drug & device makers
What this record shows
This record is dominated by grants: $50,000 of the $59,779 with a category attached, or 83.6%. Boston Scientific accounts for 91.2% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2020 at $51,576 and has fallen 94.7% since, to $2,725 in 2025. Among urology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $326.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$55K
- Coloplast$1K
- Medtronic$647
- Olympus America Inc.$514
- Biotissue Holdings Inc.$422
- Procept Biorobotics Corporation$313
- plus $2K from 20 others
What the payments were for
- Grants$50,00084%
- Travel & lodging$1,0782%
- Food & beverage$8,63314%
- Education$680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 113 | $54,534 |
| Coloplast | 12 | $1,477 |
| Medtronic(2 entities) | 9 | $647 |
| Olympus America Inc. | 5 | $514 |
| Biotissue Holdings Inc. | 6 | $422 |
| Procept Biorobotics Corporation | 4 | $313 |
| EDAP Technomed Inc | 1 | $248 |
| Sumitomo Pharma America, Inc. | 3 | $220 |
| Aroa Biosurgery Incorporated | 2 | $189 |
| Calyxo, Inc. | 4 | $168 |
| Laborie Medical Technologies Corp. | 5 | $159 |
| Dornier Medtech America, Inc | 1 | $157 |
| Kerecis Limited | 2 | $144 |
| Myovant Sciences Inc. | 1 | $119 |
| Teleflex LLC | 1 | $119 |
| Progenics Pharmaceuticals, Inc. | 1 | $64 |
| Antares Pharma, Inc. | 1 | $50 |
| AbbVie | 3 | $46 |
| Johnson & Johnson(2 entities) | 2 | $39 |
| Endo USA, Inc. | 1 | $29 |
| 180 Medical, Inc. | 1 | $27 |
| Acell, Inc. | 1 | $23 |
| Neotract Inc. | 1 | $21 |
| Tolmar, Inc. | 1 | $20 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $19 |
| Astellas Pharma US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$50,000
- TITAN$1,004
- AMS$891
- AMS 700$787
- Kerecis SurgiClose$496
- iTIND System$422
- INTERSTIM$372
- Dornier MedTech$157
- AMS 800 Artificial Urinary Sphincter$151
- CVAC Aspiration System$150
- RESTORELLE$145
- Moses 550 DFL$140
- ORGOVYX$132
- AquaBeam Robotic System$125
- Kerecis GraftGuide$124
- AMS 700 CXR RTE KIT$123
- Coloplast TFL Drive$123
- AQUABEAM SYSTEM$121
- UroLift$119
- NEOX$109
How this compares
$59,779 in reported general payments places this provider in the 95th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 39 | $38,986 |
| Tamsulosin Hcl | 128 | $2,481 |
| Estradiol | 38 | $1,895 |
| Solifenacin Succinate | 20 | $1,480 |
| Trospium Chloride | 20 | $1,382 |
| Methenamine Hippurate | 13 | $1,375 |
| Oxybutynin Chloride ErOxybutynin Chloride | 35 | $1,082 |
| Finasteride | 69 | $601 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 52 | $200 |
| Oxybutynin Chloride | 15 | $187 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $164 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 16 | $163 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $139 |
| Ciprofloxacin Hcl | 13 | $62 |
| Oxycodone Hcl | 19 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $12 | $38,98639 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 400 urology providers in Michigan.
Other urology in Warren
- Ashok ReddySterling Heights$4.9M
- William RobertsAnn Arbor$973K
- Kenneth KernenTroy$910K
- William JohnstonLivonia$675K
- Jason HafronWest Bloomfield$490K
- Khurshid GhaniAnn Arbor$413K
- Richard BennettRoyal Oak$361K
- Ryan NelsonUtica$296K
- Casey DauwAnn Arbor$188K
- Aram LoebDetroit$112K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.